Revised SPC: Lynparza (olaparib) tablets

SPC update includes myelodysplastic syndrome and acute myeloid leukaemia as uncommon adverse effects of treatment. Dyspepsia has also been added as a rare adverse drug reaction.

electronic Medicines compendium